Brief: Ryvu Therapeutics Q2 Net Loss Narrows To 28.5 Mln Zlotys
13/09/2023 07:38
Sept 13 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q2 NET LOSS 28.5 MILLION ZLOTYS VERSUS LOSS OF 36.9
MILLION
ZLOTYS YEAR AGO
* Q2 OPERATING REVENUE 15.0 MILLION ZLOTYS VERSUS 7.3
MILLION
ZLOTYS YEAR AGO
* Q2 OPERATING LOSS 31.6 MILLION ZLOTYS VERSUS LOSS OF 38.1
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM3mz8vJa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys